Sub Banner Image

Novo Gets €15 Billion of Orders for Akero Acquisition Bonds

Markets

Helene Durand

·

November 13, 2025

·

Bloomberg

Novo Nordisk A/S has pulled in more than €15 billion ($17.4 billion) of investor orders for its multi-tranche bond sale, more than triple the amount the Danish drugmaker is seeking for its planned purchase of US biotech Akero Therapeutics Inc.

More from

Bloomberg

More

Markets

Articles

Trending News

Enjoy premium content in your inbox.

You're in! Check your email to learn more.
Oops! Something went wrong while submitting the form.